⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL718531 | 1.00 | — | — | |
| SCHEMBL2794571 | 1.00 | — | — | |
| Water SCHEMBL28328238 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL2723572 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL21065373 | 0.97 | MME (0.41) | — | |
| Hydrochloric Acid SCHEMBL1458134 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL1458136 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL21065375 | 0.97 | MME (0.41) | — | |
| SCHEMBL28925035 | 0.91 | MME (0.37) | — | |
| Trifluoroacetic Acid SCHEMBL3650862 | 0.87 | MME (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 479 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250268982-A1 | COMPOSITIONS AND METHODS FOR TREATMENT AND/OR PROPHYLAXIS OF PROTEINOPATHIES | REGAIN THERAPEUTICS SWEDEN AB (SE) | 2025-08-28 | — | — | US | claimed |
| US-20250145644-A1 | PROCESSES AND COMPOUNDS FOR PREPARING SPIROLIGOMERS | TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2025-05-08 | — | — | US | claimed |
| US-20250066409-A1 | DERIVATIVE OF PENTACYCLIC TRITERPENOIDAL SAPONIN AND ITS PREPARATION METHOD AND APPLICATION | SOOCHOW UNIVERSITY (CN) | 2025-02-27 | — | — | US | claimed |
| WO-2025024501-A1 | NEUROMODULATORY PEPTIDES | LACTOCORE, INC. (US) | 2025-01-30 | — | — | WO | claimed |
| EP-4475826-A2 | PROCESSES AND COMPOUNDS FOR PREPARING SPIROLIGOMERS | Temple University Of The Commonwealth System Of Higher Education (US) | 2024-12-18 | — | — | EP | claimed |
| CN-119032097-A | Methods and compounds for preparing spiro oligomers | 宾夕法尼亚州高等教育系统天普大学 | 2024-11-26 | — | — | CN | claimed |
| EP-4347628-A2 | COMPOSITIONS AND METHODS FOR TREATMENT AND/OR PROPHYLAXIS OF PROTEINOPATHIES | Regain Therapeutics Sweden AB (SE) | 2024-04-10 | — | — | EP | claimed |
| CN-117858892-A | Compositions and methods for treating and/or preventing proteinopathies | 恢复治疗瑞典公司 | 2024-04-09 | — | — | CN | claimed |
| CN-117285626-A | Alpha v beta 6 integrin ligand and its application | 箭头药业股份有限公司 | 2023-12-26 | — | — | CN | claimed |
| WO-2023154724-A2 | PROCESSES AND COMPOUNDS FOR PREPARING SPIROLIGOMERS | TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2023-08-17 | — | — | WO | claimed |
| CN-110225899-A | Method and composition for maintaining soil nutrients in planting field | 水科学公司 | 2019-09-10 | — | — | CN | claimed |
| CN-109952376-A | α v β 6 integrin ligands and uses thereof | 箭头药业股份有限公司 | 2019-06-28 | — | — | CN | claimed |
| CN-101180029-B | Parakeratosis inhibitor, pore-shrinking agent or agent for preventing and improving rough skin, and composition for external use on skin | SHISEIDO CO LTD | 2011-02-16 | — | — | CN | claimed |
| CN-101180029-A | Parakeratosis inhibitor, pore-shrinking agent or agent for preventing and improving rough skin, and composition for external use on skin | SHISEIDO CO LTD (JP) | 2008-05-14 | — | — | CN | claimed |
| EP-1884230-A1 | PARAKERATOSIS INHIBITOR, PORE-SHRINKING AGENT OR AGENT FOR PREVENTING/AMELIORATING ROUGH SKIN AND EXTERNAL COMPOSITION FOR SKIN | Shiseido Company, Limited (JP) | 2008-02-06 | — | — | EP | claimed |
| EP-0950046-B1 | 3,4-DISUBSTITUTED AZETIDIN-2-ONE DERIVATIVES USEFUL AS CYSTEINE PROTEINASE REGULATORS | NAEJA PHARMACEUTICAL INC (CA) | 2002-04-10 | — | — | EP | claimed |
| US-6232305-B1 | ANTICANCER AGENTS; BONE DISORDERS; ANTIARTHRITIC AGENTS; RESPIRATORY SYSTEM DISORDERS | NAEJA PHARMACEUTICAL INC. (CA) | 2001-05-15 | — | — | US | claimed |
| EP-0961779-A1 | SUBSTITUTED AMINO BICYCLIC-$g(b)-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS | SYNPHAR LABORATORIES INC. (CA) | 1999-12-08 | — | — | EP | claimed |
| WO-1998032766-A1 | SUBSTITUTED AMINO BICYCLIC-β-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS | SYNPHAR LABORATORIES INC. (US) | 1998-07-30 | — | — | WO | claimed |
| EP-0293159-A2 | Parathyroid hormone antagonists with simplified synthetic methodology | MERCK & CO. INC. (US) | 1988-11-30 | — | — | EP | claimed |